Spectrum of renal diseases associated with extreme forms of insulin resistance.
about
Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation.Insulin signaling: implications for podocyte biology in diabetic kidney disease.High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo ApproachExploring metabolic dysfunction in chronic kidney disease.Novel forms of lipodystrophy: why should we care?Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophyPodocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.The long-term renal and cardiovascular consequences of prematurity.Insulin signalling to the kidney in health and disease.Lipodystrophies: adipose tissue disorders with severe metabolic implications.Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.Insulin in podocyte podiatry.Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.Glucose Transporters in Diabetic Kidney Disease-Friends or Foes?Monogenic Causes of Diabetes
P2860
Q33787727-4AE7D71E-EDB1-4893-B675-010075F79DC1Q35285585-DF854BEF-37C8-4302-9EF4-D8DF02696471Q36081651-4688E792-7364-418C-BE63-767F3F6D19BFQ36123347-20179BF7-C59D-4EF4-A505-CD4551C3FE34Q37022579-3E087472-EF78-4665-921A-005426E90CF7Q37062692-5A006365-9A31-40A2-8932-F0806F6B1CFAQ37510124-E0D05DAA-8921-45A8-BBF1-EA1523FF676FQ37590634-2945406B-1728-439B-A1C5-2726E3C16495Q37988805-C5BDEE15-7F3A-4EC9-8095-A131FEB42323Q38063325-FE85AA10-9A6C-4618-A5DC-59FE51392246Q38400624-53E3C2B9-5C58-4FCC-AA01-6071DCD56226Q39175261-7DE43113-C62B-4546-B78B-1F072F8D8566Q39404358-3E1971E9-2294-4634-AC1A-CE0D0ECF4254Q41529248-6820C8C6-A961-45D8-AF79-EB70DB0340A9Q47614541-F3081527-62DF-4FAE-9D44-4C5028B3748DQ47885313-BA6A14D0-73A2-401A-8D04-BBDC5B5C786BQ52568352-15C06495-4F20-419F-B93B-8D5017FC6052Q57915399-2F6DD159-175E-4D34-A7B5-A3A4A3A1EBDE
P2860
Spectrum of renal diseases associated with extreme forms of insulin resistance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Spectrum of renal diseases associated with extreme forms of insulin resistance.
@en
type
label
Spectrum of renal diseases associated with extreme forms of insulin resistance.
@en
prefLabel
Spectrum of renal diseases associated with extreme forms of insulin resistance.
@en
P2093
P356
P1476
Spectrum of renal diseases associated with extreme forms of insulin resistance.
@en
P2093
Carla Musso
Edward Javor
Elaine Cochran
James E Balow
Phillip Gorden
P304
P356
10.2215/CJN.01271005
P577
2006-04-26T00:00:00Z